Related Experiment Video
Updated: Oct 15, 2025

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
[Proper Perioperative Handling of Continuous Medication in Patients with Cardiac Comorbidities]
Insights
Managing cardiac comorbidities like arterial hypertension (AHT), congestive heart failure (CHF), and coronary artery disease (CAD) is crucial for perioperative care. This review details current therapies and varying international guidelines for managing these conditions during surgery.
Area of Science:
- Cardiology
- Anesthesiology
- Internal Medicine
Background:
- Cardiac comorbidities, including arterial hypertension (AHT), congestive heart failure (CHF), and coronary artery disease (CAD), represent a significant health burden in Germany.
- AHT affects one-third of adults, while CHF impacts approximately 2.5 million individuals. CAD prevalence is notable in older populations.
- Optimal perioperative care necessitates a thorough understanding of managing these cardiac conditions.
Purpose of the Study:
- To review current medical therapies for prevalent cardiac comorbidities (AHT, CHF, CAD).
- To analyze and compare international recommendations regarding the perioperative management of cardiac medications.
- To provide a comprehensive resource for optimizing risk stratification and anesthesiological care.
Main Methods:
- Systematic literature review of current medical therapies for AHT, CHF, and CAD.
- Comparative analysis of guidelines from various countries and medical societies on perioperative drug management.
- Synthesis of evidence to inform clinical practice.
Main Results:
- Current medical therapies for AHT, CHF, and CAD are established, focusing on symptom management and disease progression.
- Significant variability exists in recommendations for discontinuing or continuing cardiac medications perioperatively.
- Lack of universal consensus complicates standardized patient care.
Conclusions:
- Effective management of cardiac comorbidities requires up-to-date knowledge of treatment strategies.
- Understanding the nuances in perioperative drug management is essential for patient safety.
- Further harmonization of international guidelines could improve perioperative outcomes for patients with cardiac conditions.
Abstract:
Cardiac comorbidities place a significant burden on the German population. Every third adult is diagnosed with arterial hypertension (AHT). In 2017 congestive heart failure (CHF) pertained approximately 2,5 million of mandatory health-insured patients. Coronary artery disease (CAD) is diagnosed in 28,3% of men and 19,1% of women older than 65 years.For optimal perioperative care it is important to have a sound knowledge of current treatment strategies of cardiac comorbidities. This helps in gaining an optimal risk stratification of the individual patient. It also ensures an optimal anesthesiological perioperative care for the patient at hand. Recommendations for the perioperative discontinuation or continuation of cardiac active drugs vary between countries and responsible medical societies.This article provides an in-depth review of the current medical therapies for cardiac conditions like AHT, CHF or CAD. The varying recommendations for the perioperative discontinuation/continuation of these therapies are also reviewed.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiac Catheterization IV: Nursing Management
Pericarditis IV: Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure V: Medical Management
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...

